David Bouchey
Stock Analyst at Aegis Capital
(n/a)
# 4,697
Out of 5,140 analysts
8
Total ratings
11.11%
Success rate
-49.14%
Average return
Main Sectors:
Stocks Rated by David Bouchey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBFM Sunshine Biopharma | Reiterates: Buy | $7 | $1.18 | +493.22% | 3 | Oct 8, 2025 | |
| AEON AEON Biopharma | Reiterates: Buy | $7.2 | $1.20 | +500.00% | 1 | Oct 8, 2025 | |
| STSS Sharps Technology | Initiates: Buy | $105,600 | $1.80 | +5,866,566.67% | 1 | May 9, 2023 | |
| IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | $10 → $13 | $0.58 | +2,141.38% | 1 | Jan 25, 2023 | |
| RMTI Rockwell Medical | Downgrades: Outperform | $121 | $0.95 | +12,603.41% | 2 | Oct 19, 2018 |
Sunshine Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7
Current: $1.18
Upside: +493.22%
AEON Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7.2
Current: $1.20
Upside: +500.00%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $105,600
Current: $1.80
Upside: +5,866,566.67%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $0.58
Upside: +2,141.38%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: $121
Current: $0.95
Upside: +12,603.41%